Robert Bock, MD
Family Practice · Wayne, NJNPI 1245251891
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novo Nordisk at 27.8% of the total. Among family practice clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$619
- Lilly USA, LLC$293
- GSK$220
- Exact Sciences$162
- AstraZeneca$160
- Pfizer$139
- plus $635 from 15 others
What the payments were for
- Food & beverage$2,12896%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $619 |
| Lilly USA, LLC | 18 | $293 |
| GSK | 13 | $220 |
| Exact Sciences | 6 | $162 |
| AstraZeneca | 10 | $160 |
| Pfizer | 9 | $139 |
| Astellas Pharma US Inc | 3 | $134 |
| Merck | 6 | $101 |
| Amgen | 6 | $97 |
| Abbott | 4 | $79 |
| Dexcom, Inc. | 1 | $35 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| AbbVie | 1 | $20 |
| Cagent Vascular Inc | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$2,227 in reported general payments places this provider in the 95th percentile of 248 family practice providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 347 | $237,847 |
| MigergotErgotamine Tartrate/Caffeine | 12 | $170,609 |
| XareltoRivaroxaban | 130 | $99,940 |
| FarxigaDapagliflozin Propanediol | 82 | $63,752 |
| JardianceEmpagliflozin | 57 | $59,292 |
| JanuviaSitagliptin Phosphate | 67 | $55,165 |
| OzempicSemaglutide | 27 | $34,468 |
| MyrbetriqMirabegron | 51 | $28,627 |
| RexultiBrexpiprazole | 12 | $18,030 |
| MounjaroTirzepatide | 16 | $17,014 |
| EntrestoSacubitril/Valsartan | 16 | $16,149 |
| Atorvastatin Calcium | 951 | $14,056 |
| NamzaricMemantine Hcl/Donepezil Hcl | 21 | $13,150 |
| Spiriva HandihalerTiotropium Bromide | 11 | $13,001 |
| Vancomycin Hcl | 31 | $12,765 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $139 | $237,847347 claims |
| AmgenMigergot | $97 | $170,60912 claims |
| AstraZenecaFarxiga | $160 | $63,75282 claims |
| MerckJanuvia | $101 | $55,16567 claims |
| Novo NordiskOzempic | $619 | $34,46827 claims |
| Astellas Pharma US IncMyrbetriq | $134 | $28,62751 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $220 | $21,72542 claims |
| AbbVieNamzaric, Restasis | $20 | $21,53836 claims |
| Lilly USA, LLCMounjaro | $293 | $17,01416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 248 family practice providers in New Jersey.
Other family practice in Wayne
- Alex GuslerSomerset$6K
- Luis JaramilloWest New York$6K
- Robert LukendaCranford$5K
- Rudolph WillisIrvington$5K
- Mihir PatelBrick$5K
- Omar HassanienPassaic$3K
- Thayalan CumarasamyBurlington$2K
- Francis KielarButler$2K
- Ryan TourtellotBrick$215
- Sarah LevyBoonton$101
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.